• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SIRT1抑制STAT3和NF-κB的激活,从而抑制胃癌生长。

SIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth.

作者信息

Lu Juanjuan, Zhang Liping, Chen Xiang, Lu Qiming, Yang Yuxia, Liu Jingping, Ma Xin

机构信息

Department of Digestive Disease, Gansu Provincial Hospital 160 Donggang West Road, Lanzhou 730000, China.

出版信息

Int J Clin Exp Med. 2014 Dec 15;7(12):5050-8. eCollection 2014.

PMID:25664004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4307451/
Abstract

Sirtuin-1 (SIRT1) possesses apparently dual roles in regulation of tumor. Previous reports have documented the crosstalk between SIRT1 with signal transducer and activator of transcription 3 (STAT3) and nuclear factor kappa-B (NF-κB) signaling in leukemia, lymphoma and myeloma. In this study, the purpose was to survey the regulatory effects of SIRT1 on gastric cancer (GC) cells (AGS and MKN-45) and the relationships between SIRT1 and activation of STAT3 and NF-κB in GC cells. We found the SIRT1 activator (resveratrol RSV) contributed to the repression of viability and increase of senescence, which were rescued by SIRT1 inhibitor (nicotinamide NA) and SIRT1 depletion by CCK-8 assay and SA-β-gal assay respectively. Further study found SIRT1 activation (RSV supplement) not only inhibited the activation of STAT3 including STAT3 mRNA level, c-myc mRNA level phosphorylated STAT3 (pSTAT3) proteins and acetylizad STAT3 (acSTAT3) proteins, but also repression of pNF-κB p65 and acNF-κB p65. NA reversed the effects of RSV. In addition, either RSV or NA application could not change the cellular viability and senescence in MKN-45 cells with STAT3 knockdown or NF-κB knockdown. Overall, our findings suggested SIRT1 activation could induced the loss of viability and increases of senescence in GC in vitro. Moreover, our observations revealed SIRT1 displayed growth inhibitory activity in GC cells highly associated with causing repression of activation of STAT3 and NF-κB proteins via deacetylation.

摘要

沉默调节蛋白-1(SIRT1)在肿瘤调控中显然具有双重作用。先前的报道已记录了SIRT1与白血病、淋巴瘤和骨髓瘤中信号转导及转录激活因子3(STAT3)和核因子κB(NF-κB)信号之间的相互作用。在本研究中,目的是探究SIRT1对胃癌(GC)细胞(AGS和MKN-45)的调节作用以及SIRT1与GC细胞中STAT3和NF-κB激活之间的关系。我们发现SIRT1激活剂(白藜芦醇RSV)有助于抑制细胞活力并增加衰老,分别通过CCK-8测定法和SA-β-半乳糖苷酶测定法发现,SIRT1抑制剂(烟酰胺NA)和SIRT1缺失可挽救这些作用。进一步研究发现,SIRT1激活(补充RSV)不仅抑制STAT3的激活,包括STAT3 mRNA水平、c-myc mRNA水平、磷酸化STAT3(pSTAT3)蛋白和乙酰化STAT3(acSTAT3)蛋白,还抑制pNF-κB p65和acNF-κB p65。NA可逆转RSV的作用。此外,应用RSV或NA均不能改变STAT3或NF-κB敲低的MKN-45细胞的细胞活力和衰老。总体而言,我们的研究结果表明,SIRT1激活可在体外诱导GC细胞活力丧失和衰老增加。此外,我们的观察结果显示,SIRT1在GC细胞中表现出生长抑制活性,这与通过去乙酰化导致STAT3和NF-κB蛋白激活受抑制高度相关。

相似文献

1
SIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth.SIRT1抑制STAT3和NF-κB的激活,从而抑制胃癌生长。
Int J Clin Exp Med. 2014 Dec 15;7(12):5050-8. eCollection 2014.
2
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.NF-κB 与 SIRT1 之间的拮抗对话在炎症和代谢紊乱的调节中。
Cell Signal. 2013 Oct;25(10):1939-48. doi: 10.1016/j.cellsig.2013.06.007. Epub 2013 Jun 11.
3
Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3.多硫化物介导的 SIRT1 巯基化通过抑制 p65 NF-κB 和 STAT3 的磷酸化和乙酰化来预防糖尿病肾病。
Redox Biol. 2021 Jan;38:101813. doi: 10.1016/j.redox.2020.101813. Epub 2020 Nov 25.
4
SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells.SIRT1 过表达可降低顺铂诱导的肾近端小管细胞 NF-κB p65 亚单位乙酰化和细胞毒性。
Biochem Biophys Res Commun. 2012 Mar 9;419(2):206-10. doi: 10.1016/j.bbrc.2012.01.148. Epub 2012 Feb 5.
5
SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.SIRT1 在胃癌中表达下调,通过 NF-κB/Cyclin D1 信号通路导致 G1 期阻滞。
Mol Cancer Res. 2013 Dec;11(12):1497-507. doi: 10.1158/1541-7786.MCR-13-0214. Epub 2013 Oct 9.
6
Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of β-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-κB/BACE1 Signaling Pathways.表儿茶素和西洛他唑联合治疗通过抑制P-JAK2/P-STAT3/NF-κB/BACE1信号通路降低β-淀粉样蛋白积累和神经毒性
PLoS One. 2016 Dec 15;11(12):e0168286. doi: 10.1371/journal.pone.0168286. eCollection 2016.
7
Resveratrol Alleviates 27-Hydroxycholesterol-Induced Senescence in Nerve Cells and Affects Zebrafish Locomotor Behavior via Activation of SIRT1-Mediated STAT3 Signaling.白藜芦醇通过激活 SIRT1 介导的 STAT3 信号通路缓解 27-羟胆固醇诱导的神经细胞衰老,并影响斑马鱼的运动行为。
Oxid Med Cell Longev. 2021 Jun 21;2021:6673343. doi: 10.1155/2021/6673343. eCollection 2021.
8
The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.过氧化物酶体增殖物激活受体 β/δ(PPARβ/δ)激动剂 GW501516 通过 AMPK 和 SIRT1 减少 p65 乙酰化来防止 TNF-α 诱导的人 HaCaT 细胞中 NF-κB 的激活。
Biochem Pharmacol. 2011 Feb 15;81(4):534-43. doi: 10.1016/j.bcp.2010.12.004. Epub 2010 Dec 10.
9
JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.JAK2抑制剂通过JAK/STAT3信号通路在体外阻断食管鳞状细胞癌的炎症反应和生长。
Oncol Rep. 2015 Jan;33(1):494-502. doi: 10.3892/or.2014.3609. Epub 2014 Nov 14.
10
B1, a novel HDAC inhibitor, induces apoptosis through the regulation of STAT3 and NF-κB.新型组蛋白去乙酰化酶抑制剂B1通过调控信号转导和转录激活因子3(STAT3)及核因子κB(NF-κB)诱导细胞凋亡。
Int J Mol Med. 2017 May;39(5):1137-1148. doi: 10.3892/ijmm.2017.2946. Epub 2017 Apr 7.

引用本文的文献

1
Resveratrol modulates phosphorylation of ERK and AKT in murine cementoblasts during in vitro orthodontic compression.白藜芦醇在体外正畸加压过程中调节小鼠成牙骨质细胞中ERK和AKT的磷酸化。
BMC Oral Health. 2025 Feb 13;25(1):226. doi: 10.1186/s12903-025-05591-5.
2
Sirt6-Mediated Cell Death Associated with Sirt1 Suppression in Gastric Cancer.Sirt6介导的细胞死亡与胃癌中Sirt1的抑制相关
Cancers (Basel). 2024 Jan 16;16(2):387. doi: 10.3390/cancers16020387.
3
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review.天然 STAT3 抑制剂在癌症治疗中的应用:全面文献综述。
Recent Pat Anticancer Drug Discov. 2024;19(4):403-502. doi: 10.2174/1574892818666230803100554.
4
Overcoming Acquired Drug Resistance to Cancer Therapies through Targeted STAT3 Inhibition.通过靶向 STAT3 抑制克服癌症治疗的获得性耐药性。
Int J Mol Sci. 2023 Mar 1;24(5):4722. doi: 10.3390/ijms24054722.
5
Anti-Inflammatory Therapeutic Mechanisms of Natural Products: Insight from Rosemary Diterpenes, Carnosic Acid and Carnosol.天然产物的抗炎治疗机制:来自迷迭香二萜、鼠尾草酸和鼠尾草酚的见解
Biomedicines. 2023 Feb 13;11(2):545. doi: 10.3390/biomedicines11020545.
6
Sirtuins (SIRTs) As a Novel Target in Gastric Cancer.Sirtuins(SIRTs)作为胃癌的一个新靶点。
Int J Mol Sci. 2022 Dec 1;23(23):15119. doi: 10.3390/ijms232315119.
7
Histone Deacetylase Functions in Gastric Cancer: Therapeutic Target?组蛋白去乙酰化酶在胃癌中的作用:治疗靶点?
Cancers (Basel). 2022 Nov 7;14(21):5472. doi: 10.3390/cancers14215472.
8
Role of Post-translational Modification of Silent Mating Type Information Regulator 2 Homolog 1 in Cancer and Other Disorders.沉默交配型信息调节因子2同源物1的翻译后修饰在癌症及其他疾病中的作用
J Cancer Prev. 2022 Sep 30;27(3):157-169. doi: 10.15430/JCP.2022.27.3.157.
9
The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?胆汁酸膜受体 TGR5 在癌症中的作用:是敌是友?
Molecules. 2022 Aug 19;27(16):5292. doi: 10.3390/molecules27165292.
10
Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1.解析神经退行性疾病的治疗选择:来自 SIRT1 的见解。
J Mol Med (Berl). 2022 Apr;100(4):537-553. doi: 10.1007/s00109-022-02187-2. Epub 2022 Mar 11.

本文引用的文献

1
Loss of Sirt1 function improves intestinal anti-bacterial defense and protects from colitis-induced colorectal cancer.Sirt1功能丧失可改善肠道抗菌防御并预防结肠炎诱导的结直肠癌。
PLoS One. 2014 Jul 11;9(7):e102495. doi: 10.1371/journal.pone.0102495. eCollection 2014.
2
Histone/protein deacetylase SIRT1 is an anticancer therapeutic target.组蛋白/蛋白质去乙酰化酶SIRT1是一种抗癌治疗靶点。
Am J Cancer Res. 2014 May 26;4(3):211-21. eCollection 2014.
3
Sirt1 is a tumor promoter in lung adenocarcinoma.Sirt1是肺腺癌中的一种肿瘤促进因子。
Oncol Lett. 2014 Jul;8(1):387-393. doi: 10.3892/ol.2014.2057. Epub 2014 Apr 10.
4
Inhibition of SIRT1 signaling sensitizes the antitumor activity of silybin against human lung adenocarcinoma cells in vitro and in vivo.抑制SIRT1信号通路可增强水飞蓟宾在体外和体内对人肺腺癌细胞的抗肿瘤活性。
Mol Cancer Ther. 2014 Jul;13(7):1860-72. doi: 10.1158/1535-7163.MCT-13-0942. Epub 2014 May 5.
5
Dual role of SIRT1 in UVB-induced skin tumorigenesis.SIRT1在紫外线诱导的皮肤肿瘤发生中的双重作用。
Oncogene. 2015 Jan 15;34(3):357-63. doi: 10.1038/onc.2013.583. Epub 2014 Jan 20.
6
Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner.白藜芦醇通过以依赖Sirt1的方式诱导G1期阻滞和衰老来抑制胃癌的生长。
PLoS One. 2013 Nov 21;8(11):e70627. doi: 10.1371/journal.pone.0070627. eCollection 2013.
7
Management of gastric cancer in Asia: resource-stratified guidelines.亚洲胃癌管理:资源分层指南。
Lancet Oncol. 2013 Nov;14(12):e535-47. doi: 10.1016/S1470-2045(13)70436-4.
8
The emerging and diverse roles of sirtuins in cancer: a clinical perspective.沉默调节蛋白在癌症中的新兴及多样作用:临床视角
Onco Targets Ther. 2013 Oct 8;6:1399-416. doi: 10.2147/OTT.S37750.
9
SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.SIRT1 在胃癌中表达下调,通过 NF-κB/Cyclin D1 信号通路导致 G1 期阻滞。
Mol Cancer Res. 2013 Dec;11(12):1497-507. doi: 10.1158/1541-7786.MCR-13-0214. Epub 2013 Oct 9.
10
Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.SIRT1 调节剂在氧化应激下对 FOXOs 和 p53 的调节。
PLoS One. 2013 Sep 11;8(9):e73875. doi: 10.1371/journal.pone.0073875. eCollection 2013.